throbber
MMUNOLOGY
`
`SIXTH EDITION
`
`Thomas J. Kindt
`
`National Institutes of Health
`
`Richard A. Goldsby
`
`Amherst College
`
`Barbara A. Osborne
`
`University of Massachusetts at Amherst
`I W. H. Freeman and Company I New York
`
`Genzyme Ex. 1013, pg 293
`
`

`
`About the Cover
`The macrophage (blue) is a key player in innate immunity, sensing bacterial proteins
`through its pattern recognition receptors and then internalizing and digesting
`(phagocytosing) the invading bacteria (yellow). This encounter stimulates the
`macrophage to secrete soluble factors that attract other cells such as the monocyte
`(green) to the area of attack. (© 2004 Dennis Kunkel Microscopy, Inc.)
`
`Publisher: Sara Tenney
`Senior Acquisitions Editor: Kate Ahr
`Director of Marketing: John Britch
`Developmental Editors:Morgan Ryan,Matthew Tontonoz
`Associate Project Manager: Hannah Thonet
`Assistant Editor: Nick Tymoczko
`Media Editors: Alysia Baker,Martin Batey
`Photo Editor: Ted Szczepanski
`Photo Researcher: Dena Digilio Betz
`Text Designer:Marsha Cohen
`Cover Designer: Vicki Tomaselli
`Senior Project Editor: Georgia Lee Hadler
`Copy Editor: Karen Taschek
`Illustrations: Imagineering
`Illustration Coordinator: Susan Timmins
`Production Coordinator: Paul Rohloff
`Composition: Techbooks
`Printing and Binding: RR Donnelley
`
`Library of Congress Control Number: 2006927337
`ISBN-13: 978-1-4292-0211-4
`ISBN-10: 1-4292-0211-4
`
`© 2007 by W. H. Freeman and Company
`All rights reserved
`
`Printed in the United States of America
`
`Fifth printing
`
`W. H. Freeman and Company
`41 Madison A venue
`New York, NY 10010
`Houndmills, Basingstoke RG21 6XS, England
`www.whfreeman.com
`
`Genzyme Ex. 1013, pg 294
`
`

`
`84
`
`P A R T
`
`I I
`
`GENERATION OF B-CELL AND T-CELL RESPONSES
`
`the antibody and therefore was unable to block binding of
`HEL (4-4c).
`B-cell epitopes tend to be located in flexible regions of an
`immunogen and often display site mobility. John A. Tainer
`and his colleagues analyzed the epitopes on a number of
`protein antigens (myohemerytherin, insulin, cytochrome c,
`myoglobin, and hemoglobin) by comparing the positions of
`the known B-cell epitopes with the mobility of the same
`residues. Their analysis revealed that the major antigenic de(cid:173)
`terminants in these proteins generally were located in the
`most mobile regions. These investigators proposed that site
`mobility of epitopes maximizes complementarity with the
`antibody's binding site; more rigid epitopes appear to bind
`less effectively. However, because of the loss of entropy due
`to binding to a flexible site, the binding of antibody to a flex(cid:173)
`ible epitope is generally of lower affinity than the binding of
`antibody to a rigid epitope.
`Complex proteins contain multiple overlapping B-cell epi(cid:173)
`topes, some of which are immunodominant. For many years,
`it was dogma in immunology that each globular protein
`had a small number of epitopes, each confined to a highly
`accessible region and determined by the overall conforma(cid:173)
`tion of the protein. It has been shown more recently, how(cid:173)
`ever, that most of the surface of a globular protein is
`potentially immunogenic. This has been demonstrated by
`comparing the antigen-binding profiles of different mono(cid:173)
`clonal antibodies to various globular proteins. For example,
`when 64 different monoclonal antibodies to BSA were
`compared for their ability to bind to a panel of 10 different
`mammalian albumins, 25 different overlapping antigen(cid:173)
`binding profiles emerged, sugge ting that these 64 different
`antibodies recognized a minimum of 25 different epitopes
`on BSA.
`The surface of a protein, then, presents a large number
`of potential antigenic sites. The subset of antigenic sites on
`a given protein that is recognized by the immune system of
`an animal is much smaller than the poten ial antigenic
`repertoire, and it varies from species to specjcs and even
`among individual members of a given species. Within an
`animal, certain epitopes of an antigen are recognized as im(cid:173)
`munogenic; others are not. Furthermore, some epitopes,
`called immunodominant, induce a more pronounced im(cid:173)
`mune response in a particular animal than other epitopes.
`It is highly likely that the intrinsic topographical pr operties
`of the epitope as well as the animal's regulatory mecha(cid:173)
`nisms i11fluence the immunod mi:nance of epitopes.
`
`-----·----
`Basic Structure of Antibodies
`Recognition of an immunogen by the surface antibodies of
`the B cell triggers proliferation and differentiation into
`memory B cells and plasma cells (see Chapter 11). Plasma
`cells secrete soluble antibody molecules with specificity for
`antigen that is identical to the surface receptor of the parent
`B cell. The following sections will describe the structural
`
`features of the antibody molecules that allow them to fulfill
`their two major functions:
`
`1. Binding foreign antigens encountered by the host
`
`2. Mediating effector functions to neutralize or eliminate
`foreign invaders
`
`It has been known since the late nineteenth century that
`antibodies reside in the blood serum. (In the mid-twenti(cid:173)
`eth century, antibodies were shown to be present in other
`secreted body fluids: milk, tears, saliva, bile, etc.) Blood can
`be separated in a centrifuge into a fluid and a cellular frac(cid:173)
`tion. The fluid fraction is the plasma, and the cellular frac(cid:173)
`tion contains red blood cells, leukocytes, and platelets.
`Plasma contains all of the soluble small molecules and
`macromolecules of blood, including fibrin and other pro(cid:173)
`teins required for the formation of blood clots. If the blood
`or plasma is allowed to clot, the fluid phase that remains is
`called serum. The first evidence that antibodies were con(cid:173)
`tained in particular serum protein fractions came from a
`classic experiment by Arne Tiselius and Elvin A. Kabat in
`1939. They immunized rabbits with the protein ovalbumin
`(the albumin of egg whites), prepared serum, and then
`divided the serum into two aliquots. Electrophoretic sepa(cid:173)
`ration of one serum aliquot revealed four major fractions
`corresponding to serum albumin and the alpha (a), beta
`([3 ), and gamma ( 'Y) globulins. Prior to electrophoresis, the
`other serum aliquot was mixed with the immunizing antigen
`(ovalbumin), allowing formation of an immune precipitate
`
`8
`
`Albumin
`
`f-- - - - Globulins - -- - - 7
`
`y
`
`Migration distance
`
`FIGURE 4- 5 Experimental demonstration that most antibodies
`are in the 'Y-globulin fraction of serum proteins. After rabbits were
`immunized with ovalbumin (OVA), their antisera were pooled and
`electrophoresed, which separated the serum proteins according to
`their electric charge and mass. The blue line shows the electrophoretic
`pattern of untreated antiserum. The black line shows the pattern of
`antiserum that was first incubated with OVA to remove anti-OVA an(cid:173)
`tibody and then subjected to electrophoresis. {Adapted from A. Tise/ius
`and E. A Kabat, 1939, journal of Experimental Medicine 69:119, with copyright
`permission of the Rockefeller University Press.]
`
`Genzyme Ex. 1013, pg 295
`
`

`
`(complex of antigen and antibody) that was removed, leav(cid:173)
`ing the remaining serum proteins, which did not react with
`the antigen. A comparison of the electrophoretic profiles of
`these two serum aliquots revealed that there was a signifi(cid:173)
`cant drop in the )'-globulin peak in the aliquot that had
`been reacted with antigen (Figure 4-5) . Thus, the )'-globulin
`fraction was identified as containing serum antibodies,
`which were called immunoglobulins to distinguish them
`from any other proteins that might be contained in the )'(cid:173)
`globulin fraction. The early experiments of Kabat and
`Tiselius resolved serum proteins into three major nonalbu(cid:173)
`min fractions-ex, [3, and 'Y· We now know that although
`immunoglobulin G (IgG), the most abundant class of anti(cid:173)
`body molecules, is indeed mostly found in the )'-globulin
`fraction, significant amounts of it and other important
`classes of antibody molecules are found in the ex and the f3
`fractions of serum.
`
`Antibodies are heterodimers
`
`Antibody molecules have a common structure of four
`peptide chains (Figure 4-6). This structure consists of two
`identical light (L) chains, polypeptides of about 22,000 Da,
`and two identical heavy (H) chains, larger polypeptides
`of around 55,000 Da or more. Each light chain is bound to
`a heavy chain by a disulfide bond and by noncovalent interac(cid:173)
`tions such as salt linkages, hydrogen bonds, and hydrophobic
`interactions to form a heterodimer (H-L). Similar noncovalent
`interactions and disulfide bridges link the two identical
`heavy and light (H-L) chain combinations to each other to
`form the basic four-chain (H-L) 2 antibody structure, a
`dimer of dimers. As we will see, the exact number and pre(cid:173)
`cise positions of the disulfide bonds linking dimers differs
`among antibody classes and subclasses.
`The first 110 or so amino acids of the amino-terminal
`region of a light or heavy chain varies greatly among anti(cid:173)
`bodies of different antigen specificity. These segments of
`highly variable sequence are called V regions: V L in light
`chains and V H in heavy. All of the differences in specificity
`displayed by different antibodies can be traced to differ(cid:173)
`ences in the amino acid sequences of V regions. In fact,
`most of the differences among antibodies fall within areas
`of the V regions called complementarity-determining re(cid:173)
`gions (CDRs), and it is these CDRs, on both light and
`heavy chains, that constitute the antigen binding site of
`the antibody molecule. By contrast, within each particular
`class of antibody, far fewer differences are seen when one
`compares sequences throughout the rest of the molecule.
`The regions of relatively constant sequence beyond the
`variable regions have been dubbed C regions, CL in light
`chains and CH in heavy. Antibodies are glycoproteins; with
`few exceptions, the sites of attachment for carbohydrates
`are restricted to the constant region. We do not completely
`understand the role played by glycosylation of antibodies,
`but it probably increases the solubility of the molecules.
`Inappropriate glycosylation or its absence affects the rate
`
`ANTIGENS AND ANTIBODIES
`
`c H A P T E R
`
`85
`
`l'll>liii - - (cid:173)
`/k:l\ )
`,LL { . u . i). t H~ t:.
`
`coo-
`
`coo-
`
`:llfl\ l f} I rtl Till(
`
`FIGURE 4-6 Schematic diagram of structure of immunoglobu(cid:173)
`lins derived from amino acid sequence analysis. Each heavy and
`light chain in an immunoglobulin molecule contains an amino-terminal
`variable (V) region (aqua and tan, respectively) that consists of 100 to
`110 amino acids and differs from one antibody to the next. The re(cid:173)
`mainder of each chain in the molecule-the constant (C) regions
`(purple and red)-exhibits limited variation that defines the two
`light-chain subtypes and the five heavy-chain subclasses. Some heavy
`chains ('y, 8, and ex) also contain a proline-rich hinge region (black). The
`amino-terminal portions, corresponding to the V regions, bind to anti(cid:173)
`gen; effector functions are mediated by the carboxy-terminal do(cid:173)
`mains. The fL and E heavy chains, which lack a hinge region, contain an
`additional domain in the middle of the molecule. CHO denotes a car(cid:173)
`bohydrate group linked to the heavy chain.
`
`at which antibodies are cleared from the serum and
`decreases the efficiency of interaction between antibody
`and other proteins with which it interacts.
`
`Chemical and enzymatic methods revealed
`basic antibody structure
`Our knowledge of basic antibody structure was derived
`from a variety of experimental observations. When the )'(cid:173)
`globulin fraction of serum is separated into high- and
`low-molecular-weight fractions, antibodies of around
`150,000 Da, designated as immunoglobulin G (IgG), are
`found in the low-molecular-weight fraction. In a key ex(cid:173)
`periment, brief digestion of IgG with the proteolytic en(cid:173)
`zyme papain produced three fragments, two of which were
`identical, with a third that was quite different (Figure 4-7).
`The two identical fragments (45,000 Da each) had antigen(cid:173)
`binding activity and were called Fab fragments ("fragment,
`antigen binding"). The other fragment (50,000 Da) had
`no antigen-binding activity at all. Because it was found to
`crystallize during cold storage, it was called the Fe fragment
`
`L_ __ _
`
`Genzyme Ex. 1013, pg 296
`
`

`
`130
`
`P A R T
`
`I I GENERATION OF B-CELL AND T-CELL RESPONSES
`
`- - - - · -- - - - - - - - - - - - - - - - ,
`
`(a) IgM in response to immunization
`First
`Second
`immunization immunization
`-J,
`
`0.6
`
`IgG in response to immunization
`First
`Second
`immunization immunization
`
`0.4
`
`- 0.5
`
`...
`·a 0.4
`;J
`~ 0.3
`-~
`0.2
`~
`
`o AID-;-
`• AID +!-
`
`0
`
`0
`0
`
`15
`
`0
`
`0
`0
`
`•
`••
`
`30
`
`Day
`
`•
`
`I
`
`15
`
`I •
`
`30
`
`(b) Mutations in variable-region mRNA
`
`AID(+/-)
`
`CDR!
`
`CDR2
`
`N terminal
`
`V H messenger RNA
`
`FIGURE 5-17 Experimental demonstration of
`the role of the enzyme AID in class switching
`and somatic hypermutation. (a) AID-expressing
`( + /-) and AID knockout (-/-) mice were immu(cid:173)
`nized twice with a hapten-carrier conjugate and
`the antihapten antibody responses measured and
`plotted in arbitrary units. lgM responses were
`detected in both types of mice. Production of lgG,
`which requires class switching, occurred only in
`AID-expressing ( +/-) mice. (b) Messenger RNA
`encoding the variable regions of antigen-reactive
`antibodies in immunized AID-expressing and AID
`knockout mice was sequenced and the position
`and frequency of mutations plotted. Many muta(cid:173)
`tions are seen in the AID-expressing mice; only
`background levels of mutation are seen in the AID
`knockout mice. {Adapted from M. /VIuramatsu et a/.,
`2000, Cell102:560.}
`
`Expression of lg Genes
`As is true for many genes, post-transcriptional processing of
`immunoglobulin primary transcripts is required to produce
`functional mRNAs (see Figures S-4 and 5-S). The primary
`transcripts produced from rearranged heavy-chain and light(cid:173)
`chain genes contain intervening DNA sequences that include
`noncoding introns and J gene segments not lost during V-(D)(cid:173)
`J rearrangement. In addition, as noted earlier, the heavy-chain
`C-gene segments are organized as a series of coding exons and
`noncoding introns. Each exon of a CH gene segment corre(cid:173)
`sponds to a constant-region domain or a hinge region of the
`heavy-chain polypeptide. The primary transcript must be pro(cid:173)
`cessed to remove the intervening DNA sequences, and the re(cid:173)
`maining exons must be connected by a process called RNA
`splicing. Short, moderately conserved splice sequences, or
`splice sites, which are located at the intron-exon boundaries
`within a primary transcript, signal the positions at which splic(cid:173)
`ing occurs. Processing of the primary transcript in the nucleus
`
`removes each of these intervening sequences to yield the final
`mRNA product. The mRNA is then exported from the nucleus
`to be translated by ribosomes into complete H or L chains.
`
`Heavy-chain primary transcripts undergo
`differential RNA processing
`
`Processing of an immunoglobulin heavy-chain primary
`transcript can yield several different mRNAs, which explains
`how a single B cell can produce secreted or membrane(cid:173)
`bound forms of a particular immunoglobulin and simulta(cid:173)
`neously express IgM and IgD.
`
`Expression of Membrane or Secreted Immunoglobulin
`As explained in Chapter 3, a particular immunoglobulin can
`exist in either membrane-bound or secreted form. The two
`forms differ in the amino acid sequence of the heavy-chain
`carboxyl-terminal domains (CH3/CH3 in IgA, IgD, and IgG
`and CH4/CH4 in IgE and IgM). The secreted form has a
`
`Genzyme Ex. 1013, pg 297
`
`

`
`(a)
`
`\
`
`563
`
`556
`
`Key:
`
`0 Hydrophilic
`0 Hydrophobic
`
`556
`
`Outside
`
`............. 568
`
`Encod ed
`by S exon
`o f C1,
`
`Encoded by
`Ml and M2
`cxom. ofC11
`
`576
`
`Membrane
`
`SS bridge
`
`575
`576
`
`COOH
`
`............. 594
`
`597
`Cytoplasm
`
`Secreted 11
`
`Membrane 11
`
`COOH
`
`Cs
`
`(b)
`
`Primary
`H-chain
`transcript
`
`VDJ
`L ,---A---, ]
`
`111
`
`112
`
`113
`
`114 S M 1 M2
`
`site 1
`
`site 2
`
`site 3
`
`site 4
`
`I Polyadenylation
`Sit~te2
`
`RNA transcript for secreted 11
`L V DJ J
`111
`112
`113
`
`114 S
`
`RNA transcript for membrane 11
`L VDJ]
`111
`112
`113
`
`114SM1M2
`
`(A),
`
`(A)"
`
`1 RNA splicing
`
`LV DJ 111 112113 114S
`
`(A)"
`
`mRNA encoding secreted 11 chain
`
`mRNA encoding membrane 11 chain
`
`FIGURE 5-18 Expression of secreted and membrane forms of
`the heavy chain by alternative RNA processing. (a) Amino acid se(cid:173)
`quence of the carboxyl-terminal end of secreted and membrane fJ..
`heavy chains. Residues are indicated by the single-letter amino acid
`code. Hydrophilic and hydrophobic residues and regions are indicated
`by purple and orange, respectively, and charged amino acids are indi-
`
`cated with a + or -.The white regions of the sequences are identi(cid:173)
`cal in both forms. (b) Structure of the primary transcript of a rear(cid:173)
`ranged heavy-chain gene showing the Cf'- exons and poly-A sites.
`Polyadenylation of the primary transcript at either site 1 or site 2 and
`subsequent splicing (indicated by V-shaped lines) generates mRNAs
`encoding either secreted or membrane fJ.. chains.
`
`hydrophilic sequence of about 20 amino acids in the
`carboxyl-terminal domain; this is replaced in the mem(cid:173)
`brane-bound form with a sequence of about 40 amino acids
`containing a hydrophilic segment that extends outside the
`
`cell, a hydrophobic transmembrane segment, and a short hy(cid:173)
`drophilic segment at the carboxyl terminus that extends into
`the cytoplasm (Figure 5-18a). For some time, the existence
`of these two forms seemed inconsistent with the structure of
`
`131
`
`Genzyme Ex. 1013, pg 298
`
`

`
`132
`
`P A R T
`
`I I
`
`GENERATION OF B-CELL AND T-CELL RESPONSES
`
`germ-line heavy-chain DNA, which had been shown to con(cid:173)
`tain a single CH gene segment corresponding to each class
`and subclass.
`The resolution of this puzzle came from DNA sequencing
`ofthe
`gene segment, which on .ists of four exons (CJJJl,
`~' and C 4) corresponding to the four domains of
`2,
`tl:e IgM Jnolecul~. The
`,...4 exon contains a nucl.eotide se(cid:173)
`q)lence (caUed S) at its 31 end that encodes the hydrophilic
`sequence in the CH4 domain of secreted IgM. Two additional
`exons called M1 and M2 are located 1.8 kb downstream
`from the 3 1 end of the CfL4 exon. The M1 exon encodes the
`transmembrane segment, and M2 encodes the cytoplasmic
`segment of the CH4 domain in membrane-bound IgM. DNA
`sequencing revealed that all the CH gene segments have two
`additional downstream M1 and M2 exons that encode the
`transmembrane and cytoplasmic segments.
`The primary transcript produced by transcription of are(cid:173)
`arranged I.L heavy-chain gene contains two polyadenylation
`signal sequences, or poly-A sites, in the CfL segment. Site 1 is
`located at the 3 1 end of the CfL 4 exon, and site 2 is at the 3 1
`
`end of the M2 exon (Figure 5-18b ). If cleavage of the pri(cid:173)
`mary transcript and addition of the poly-A tail occurs at site
`1, the M 1 and M2 exons are lost. Excision of the introns and
`splicing of the remaining exons then produces mRNA en(cid:173)
`coding the secreted form of the heavy chain. If cleavage and
`polyadenylation of the primary transcript occurs instead at
`site 2, then a different pattern of splicing results. In this case,
`splicing removes the S sequence at the 3 1 end of the CfL4
`exon, which encodes the hydrophilic carboxyl-terminal end
`of the secreted form and joins the remainder of the CfL 4 exon
`with the M1 and M2 exon , producing mRNA for the mem(cid:173)
`brane form of the heavy chain.
`Thus, differential processing of a common primary tran(cid:173)
`script determines whether the secreted or membrane form of
`an immunoglobulin will be produced. As noted previously,
`mature naive B cells produce only membrane-bound antibody,
`whereas differentiated plasma cells produce secreted antibod(cid:173)
`ies. It remains to be determined precisely how naive B cells and
`plasma cells direct RNA processing preferentially toward the
`production of mRNA encoding one form or the other.
`
`(a) H-chain primary transcript
`
`c~
`
`Co
`
`VDJ
`L~J
`
`5'
`
`I
`\
`-6.5
`kb
`
`~-tl
`
`~-t2
`
`~-t3
`
`~-t4 s
`
`M1 M2
`
`01
`
`02
`
`03 s
`
`M1M2
`
`site 1
`
`site 2
`
`site 3
`
`site 4
`
`3'
`
`\ Poly-A
`
`(b) Polyadenylation of primary transcript at site 2 ---7 llm
`c;~,
`
`VDJ
`Lr-"--, J
`
`s
`
`Ml M2
`
`llm transcript 5'
`
`l splicing
`
`~-tmmRNA
`
`5'
`
`(c) Polyadenylation of primary transcript at site 4 ---7 om
`c~
`
`Om transcript 5'
`
`)J.4 s
`
`M1 M2
`
`01
`
`02
`
`03 s
`
`MlM2
`
`FIGURE 5-19 Expression of membrane forms of IL and 8 heavy
`chains by alternative RNA processing. (a) Structure of rearranged
`heavy-chain gene showing CfL and C8 exons and poly-A sites. {b)
`Structure of ILm transcript and ILm mRNA resulting from polyadenyla-
`
`tion at site 2 and splicing. (c) Structure of 8m transcript and 8m mRNA
`resulting from polyadenylation at site 4 and splicing. Both processing
`pathways can proceed in any given B cell.
`
`Genzyme Ex. 1013, pg 299
`
`

`
`ORGANIZATION AND EXPRESSION OF IMMUNOGLOBULIN GENES
`
`c H A P T E R
`
`133
`
`Simultaneous Expression of lgM and lgD
`Differential RNA processing also underlies the simultane(cid:173)
`ous expression of membrane-bound IgM and IgD by
`mature B cells. As mentioned already, transcription of
`rearranged heavy-chain genes in mature B cells produces
`primary transcripts containing both the C,.,. and C6 gene
`segments. The CIJ. and C8 gene segments are close together
`in the rearranged gene (only about 5 kb apart), and the lac.l<
`of a switch site b tween them permits the entire VDJC C0
`region to be transcribed into a single primary RNA tian(cid:173)
`script about 15 kb long, which contains four poly-A sites
`(Figme 5-19). Sites 1 and 2 are associated with C , as de(cid:173)
`scribed in the previous section; sites 3 and 4 are i<~cated at
`similar places in the C0 gene segment. If the heavy-chain
`transcript is cleaved and polyadenylated at site 2 after the
`C exons, then the mRNA will encode the membrane form
`of the fL heavy chain (Eigure 5-19b); if polyadenylation is
`instead further downstream at site 4, after the C0 exons,
`then RNA splicing will remove the intervening C exo.ns
`and produce mRNA encoding the membrane form 6t the 5
`heavy chain (Figure 5-19c).
`Since the mature B cell expresses both IgM and IgD on its
`membrane, both processing pathways must occur simultane(cid:173)
`ously. Likewise, cleavage and polyadenylation of the primary
`heavy-chain transcript at poly-A site 1 or 3 in plasma cells
`and subsequent splicing will yield the secreted form of the fL
`oro heavy chains, respectively (see Figure 5-18b).
`
`Synthesis, Assembly, and Secretion
`of Immunoglobulins
`Antibody production poses unique problems related to the
`variability of the product and the amount that is produced. An
`extraordinarily diverse repertoire of antibodies is produced by
`the mechanisms of gene rearrangements, imprecise joining of
`V-(D)-J segments, addition of nucleotides to the cleaved ends
`of these segments, and, in many cases, somatic hypermutation,
`but an expensive byproduct of all this variability is the genera(cid:173)
`tion of a significant number of antibody genes that harbor pre(cid:173)
`mature stop codons or produce immunoglobulins that do not
`fold or assemble properly. A second problem arises from the
`scale of antibody production by plasma cells. In addition to the
`proteins required for all of their normal metabolic activities,
`plasma cells manufacture and secrete more than 1000 antibody
`molecules per cell per second. Simply moving the intracellular
`vesicles containing cargoes of antibody to the plasma mem(cid:173)
`brane for discharge requires a remarkable feat of intracellular
`traffic control and coordination.
`Like all proteins destined for incorporation into mem(cid:173)
`branes or discharge to the extracellular environment, im(cid:173)
`munoglobulin polypeptides are synthesized in the rough
`endoplasmic reticulum (RER). Immunoglobulin heavy- and
`light-chain mRNAs are translated on separate polyribo(cid:173)
`somes of the RER (Figure 5-20). Newly synthesized chains
`
`contain an amino-terminal leader sequence, which serves to
`guide the chains into the lumen of the RER, where the signal
`sequence is then cleaved. The order of assembly of light (L)
`and heavy (H) chains varies among the immunoglobulin
`classes. In the case of IgM, the L and H chains assemble
`within the RER to form half-molecules, and then two half(cid:173)
`molecules assemble to form the complete molecule. In the
`case oflgG, two H chains assemble, then an H2L intermedi(cid:173)
`ate is assembled, and finally the complete H2L2 molecule is
`formed. Enzymes present in the RER catalyze the formation
`of the interchain disulfide bonds necessary for assembly of
`immunoglobulin polypeptides, as well as the intrachain-S-S
`bonds that secure the folding of immunoglobulin domains.
`The glycosylation of antibody molecules is also carried out
`by enzymes of the RER.
`Antibodies are directed to their destinations (either se(cid:173)
`creted or bound to the membrane) based on the presence of
`hydrophobic or hydrophilic carboxyl-terminal domains on
`their heavy chains, mentioned earlier. Membrane-bound an(cid:173)
`tibodies contain the hydrophobic sequence, which becomes
`anchored in the membrane of a secretory vesicle. When the
`vesicle fuses with the plasma membrane, the antibody takes
`up residence in the plasma membrane (Figure 5-20, inset at
`top). Antibodies containing the hydrophilic sequence char(cid:173)
`acteristic of secreted immunoglobulins are transported as
`free molecules in secretory vesicles and are released from the
`cell when these vesicles fuse with the plasma membrane.
`The ER has quality control mechanisms (Figure 5-21),
`which ensure the export of only completely assembled anti(cid:173)
`body molecules and promote the destruction of incomplete
`or improperly folded Ig molecules. One mediator of these
`functions is BiP (immunoglobulin heavy chain binding pro(cid:173)
`tein), which binds to incompletely assembled antibody
`molecules but dissociates from completely assembled ones.
`A specific sequence of amino acids in BiP (lysine-glutamate(cid:173)
`aspartate-leucine) causes it to be retained in the endoplas(cid:173)
`mic reticulum, preventing incomplete antibody molecules to
`which it is bound from leaving the ER. Antibody molecules
`that are misfolded or retained in the ER eventually become
`labeled for degradation by attachment of a protein called
`ubiquitin. Proteins tagged with ubiquitin are translocated
`out of the nucleus and subjected to proteolysis by proteo(cid:173)
`somes, large multienzyme complexes that will be discussed
`more fully in Chapter 8.
`
`Regulation of lg-Gene Transcription
`Immunoglobulin genes are expressed only in B-lineage cells,
`and even within this lineage, the genes are expressed at differ(cid:173)
`ent rates during different developmental stages. As with other
`eukaryotic genes, two major classes of cis regulatory sequences
`in DNA regulate transcription of immunoglobulin genes:
`
`• Promoters: relatively short nucleotide sequences,
`extending about 200 bp upstream from the transcription
`
`Genzyme Ex. 1013, pg 300
`
`

`
`134
`
`p A R T
`
`I 1 GENERATION OF B-CELL AND T-CELL RESPONSES
`
`Membrane Ig
`~I!
`~ fl.-~
`Fusion with
`membrane
`
`/,'1)
`} ~ Secretory vesicle
`
`)
`Transmembrane
`segment
`
`Oligosaccharides
`
`proteasome
`
`;Cj:
`'I'
`!1{1? Degradation by
`T
`l
`T
`T
`Retention in ER bound to BiP
`l
`
`Ubiquitin ~ Ubiquitination
`2r
`
`Export to cytosol
`
`BiP
`
`f
`
`Disassembly
`
`Trans Golgi
`
`Trans Golgi
`
`Cis Golgi
`
`RER
`
`~
`j
`~.a Uu
`( ,--7 fT
`)! :_:./'
`
`..... ~~~j"tl
`
`Light-chain
`translation
`
`Nascent Ig Heavy-cham
`(leader
`translation
`cleaved)
`
`FIGURE 5-20 Synthesis, assembly, and secretion of the im(cid:173)
`munoglobulin molecule. The heavy and light chains are synthe(cid:173)
`sized on separate polyribosomes (polysomes). The assembly of the
`chains, the formation of intrachain and interchain disulfide link(cid:173)
`ages, and the addition of carbohydrate all take place in the rough
`endoplasmic reticulum (RER). Vesicular transport brings the lg to
`the Golgi, Which It transits, departing in vesicles that fuse with the
`cell membrane. The main figure depicts the assembly of a secreted
`antibody. The Inset depicts a membrane-bou nd ant ibody, wh ich
`contains the carboxyl-terminal transmembra ne segment. This fo rm
`becomes anchored in the m·embrane of ~ecretory vesicles and Is
`retained in t he cell membrane when the vesicles fuse with t he cell
`membrane.

`
`Nascent Ig
`(leader cleaved)
`
`FIGURE 5-21 Quality control during antibody synthesis. lg
`molecules that fail to fold or assemble properly remain bound to the
`chaperone protein BiP. Interaction with BiP and other factors causes
`the malformed antibody to be disassembled, exported from the ER,
`marked for degradation by conjugation with ubiquitin, and degraded
`by the proteosome.
`
`initiation site, that promote initiation of RNA
`transcription in a specific direction
`
`Enhancers: nucleotide sequences situated some distance
`upstream or downstream from a gene that activate
`transcription from the promoter sequence in an
`orientation-independent manner
`
`The locations of the regulatory elements in germ-line im(cid:173)
`munoglobulin DNA are shown in Figure 5-22. All of these
`regulatory elements have clusters of sequence motifs that
`can bind specifically to one or more nuclear proteins.
`Each V H and V L gene segment has a promoter located just
`upstream from the leader sequence. In addition, the JK cluster
`and each of the DH genes of the heavy-chain locus are pre(cid:173)
`ceded by promoters. Like other promoters, the immunoglob(cid:173)
`ulin promoters contain a highly conserved AT-rich sequence
`called the TATA box, which serves as the binding site for a
`number of proteins necessary for the initiation of RNA tran(cid:173)
`scription. The actual process of transcription is performed by
`RNA polymerase II, which starts transcribing DNA from the
`initiation site, located about 25 bp downstream of the TATA
`box. Ig promoters also contain an essential and conserved oc(cid:173)
`tamer that confers B-ee!! specificity on the promoter. The oc(cid:173)
`tamer binds two transcription factors, oct -1, found in many
`cell types, and oct-2, found only in B cells.
`
`Genzyme Ex. 1013, pg 301

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket